Welcome to JDD Corner, your gateway to a world of dermatology knowledge and insights! JDD Corner is a curated collection of video abstracts, editor picks, Key Opinion Leader (KOL) spotlights, trending articles, and much more. Whether you are a dermatologist, a skincare enthusiast, or simply curious about the latest advancements in dermatology, JDD Corner is your one-stop destination for staying informed and up-to-date with the most exciting developments in the field. Explore our carefully selected content and immerse yourself in the dynamic world of dermatology. Welcome to JDD Corner!
JDD Corner
JDD Corner
Video Abstracts
Introducing an Exciting NEW Opportunity for Our Authors to Connect with Our Readership through a Cutting-Edge Media Channel! Email us at editorial@jddonline.com to get started!
NEW! VIDEO ABSTRACT
Acetyl Dipeptide-31 Amide: A Novel Cosmetic Anti-Inflammatory Peptide That Demonstrates Anti-Aging, Firming, and Lifting Benefits
There is continuous demand for safe, effective cosmetic ingredients to treat the signs of aging skin, including fine lines, wrinkles, brown spots, discoloration, laxity, and sagging. While there are a plethora of cosmeceutical peptides, few combine anti-aging and anti-inflammatory benefits with small size.
NEW! VIDEO ABSTRACT
GLP-1 Receptor Agonists for the Dermatologist: Uses and Considerations
The glucagon-like peptide-1 receptor agonists (GLP1RAs) are a widely popularized drug class due to their notable success in promoting weight loss. The GLP1RAs, dulaglutide, exenatide, semaglutide, liraglutide, tirzepatide, and lixisenatide are FDAapproved for use in the treatment of obesity and type 2 diabetes mellitus (DM), particularly to reduce cardiovascular risk and improve glycemic control.1,2,3 GLP1RAs work by mimicking glucagon-like peptide-1 (GLP-1), an incretin, that functions to subdue appetite, delay gastric emptying, and regulate homeostasis of glucose.
NEW! VIDEO ABSTRACT
New Formulations of Acyclothymidine Dinucleosides Reduce Damaging Effects of Ultraviolet Radiation in an Ex Vivo Skin Model
The greatest risk factor for skin cancer is exposure to ultraviolet (UV) rays of the sun. Among the three types of solar radiation (UVA, UVB, UVC), UVB rays are most commonly associated with skin cancer. UVB exposure promotes the formation of cyclobutane pyrimidine dimers (CPDs) in the DNA of cells in the epidermal skin layers, which can lead to mutations as DNA repair machinery attempts to repair the damage.
NEW! VIDEO ABSTRACT
Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema
The role of the vehicle in topical prescription treatments is to deliver therapeutic concentrations of an active drug to a designated skin target site to support patient adherence and satisfaction, ideally without skin irritation. To achieve a pharmacological effect, the drug must be able to penetrate through the stratum corneum (SC) into the viable epidermis and dermis. The skin barrier is composed of terminally differentiated keratinocyte cells (corneocytes) and lipid lamellae, which prevent the movement of water out of the skin.
VIDEO ABSTRACT
Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis
Understanding IL-23 Biologics
IL-23 biologics are designed to bind to specific regions (epitopes) on the p19 or p40 subunits, preventing IL-23 from activating its receptor and triggering the inflammatory cascade responsible for psoriasis.
VIDEO ABSTRACT
Pathophysiologic Targets for Acne Treatment
Acne vulgaris is an extremely common dermatologic condition. Individuals with acne present not only to dermatologists, but also to internists, family medicine physicians, pediatricians, estheticians, and beauty counters alike in search of a treatment. The diagnosis of acne is relatively straightforward, leading many to believe that acne is a simple condition.
Author Spotlight
Deborah S. Sarnoff MD
JDD Editor-in-Chief
JDD Editor-in-Chief
The Journal of Drugs in Dermatology is proud to announce Deborah S. Sarnoff MD as our new Editor-in-Chief. Please check out her first announcement of all the latest updates at JDD.
Read More
Trending Articles
An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris
Acne vulgaris is a common, chronic cutaneous disorder with numerous efficacious prescription and procedural treatments. Therapy, however, is hampered by medication intolerability and compromised by non-adherence. The use of acneceuticals is an effective way to improve patient outcomes.
Read More
The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic autoinflammatory condition notable for a high psychosocial burden on patients. This burden is theorized to be linked to patient dissatisfaction due to the paucity of treatment options.
Read More
Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature
Epidermolysis bullosa acquisita (EBA) is a rare autoimmune disorder characterized by blistering of the skin and mucous membranes. Current pathophysiology implicates autoantibodies targeting type VII collagen, which serves as a crucial component of anchoring fibrils that attach the epidermis to the dermis.
Read More
Single-Center, Open-Label Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum
REVIVV® is a topical hair growth serum with a proprietary formula of botanicals that addresses multiple factors involved in hair loss pathophysiology.
Read More
Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%
Topical medications commonly prescribed for the treatment of acne vulgaris may be limited by application-site dryness, which can result in skin barrier damage. This study aimed to evaluate the effects of clascoterone cream 1% on skin barrier properties in acne-prone individuals.
Read More
Artificial Intelligence-Generated Educational Curriculum on Facial Neurotoxin Injections:
Large language models (LLMs) have revolutionized the way physicians access and leverage artificial intelligence (AI). The potential role of AI in facilitating aesthetic medical education remains to be established.
Read More
Recent News
Editor's Picks
Video Pearls
Tough Day at the Office: Lupus, Sarcoidosis, and a Side of Morphea
Watch as Dr. Friedman shares basic principles to managing three distinct diseases – cutaneous lupus, sarcoidosis and linear morphea. Learn why you need to do a good review of organ systems and be prepared to phone a friend (or more) across the aisle in medicine.
Tips for Providing Better Atopic Dermatitis Care
With the growing list of therapeutic options, Dr. Friedman encourages clinicians to go back to the basics and address one of the greatest challenges — treatment adherence.
Acne and Diet
Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences. Dr. Friedman says acne is an evidence-based example of the saying “you are what you eat.”
Crushing It In The Capital: Lessons From Residency Translated
Dr. Friedman provides his tips for remaining calm during the craziest of office visits. He also shares why being fun, creative and an off-label bandit matters.
New Innovations in Hyperpigmentation
Dr. Chilukuri outlines at-home and in-office treatments to address hyperpigmentation, including newly developed therapies.
